IMMUCELL CORP /DE/
Develops and markets products to improve the health of dairy and beef cattle.
ICCC | US
Overview
Corporate Details
- ISIN(s):
- US4525253062
- LEI:
- Country:
- United States of America
- Address:
- 56 EVERGREEN DR, 4103 PORTLAND
- Website:
- https://immucell.com/
- Sector:
- Manufacturing
Description
ImmuCell Corporation is an animal health company that develops, manufactures, and markets scientifically-proven products to improve the health and productivity of dairy and beef cattle. The company focuses on disease prevention as a means to reduce the use of antibiotics. Its flagship product line, First Defense®, is a USDA-accredited, colostrum-derived product providing newborn calves with immediate immunity against the primary viral and bacterial causes of scours. ImmuCell is also developing Re-Tain®, a purified nisin-based intramammary treatment for subclinical mastitis in dairy cows, which is pending regulatory approval. The company's core competency lies in its ability to concentrate, purify, and quantify specific colostrum antibodies on a commercial scale to create cost-effective health solutions for producers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-26 21:00 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2024-08-22 19:05 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2024-08-19 19:04 |
PRIMARY DOCUMENT
|
English | 6.9 KB | ||
| 2024-08-13 22:05 |
QUARTERLY REPORT
|
English | 2.2 MB | ||
| 2024-08-13 22:05 |
CURRENT REPORT
|
English | 112.2 KB | ||
| 2024-07-09 22:05 |
CURRENT REPORT
|
English | 96.7 KB | ||
| 2024-06-14 19:38 |
CURRENT REPORT
|
English | 87.2 KB | ||
| 2024-06-14 17:33 |
CURRENT REPORT
|
English | 80.2 KB | ||
| 2024-06-06 13:49 |
CURRENT REPORT
|
English | 92.9 KB | ||
| 2024-05-22 22:50 | English | 15.0 KB | |||
| 2024-05-14 22:06 |
QUARTERLY REPORT
|
English | 2.1 MB | ||
| 2024-05-14 22:05 |
CURRENT REPORT
|
English | 108.8 KB | ||
| 2024-04-26 15:00 |
PROXY STATEMENT
|
English | 760.1 KB | ||
| 2024-04-10 06:15 | English | 5.0 KB | |||
| 2024-04-10 01:52 |
PROSPECTUS
|
English | 39.3 KB |
Automate Your Workflow. Get a real-time feed of all IMMUCELL CORP /DE/ filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IMMUCELL CORP /DE/
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IMMUCELL CORP /DE/ via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
